An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Fexinidazole

Chemical NameFexinidazole
Dosage FormTablet (oral; 600 mg)
Drug ClassAntimicrobials
SystemNervous
CompanySanofi-Aventis
Approval Year2021

Indication

  • Indicated for the treatment of both first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in patients 6 years of age and older and weighing at least 20 kg.
Last updated on 11/30/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Fexinidazole (fexinidazole) Prescribing Information2021Sanofi-aventis U.S. LLC, Bridgewater, NJ
Document TitleYearSource
Efficacy and toxicity of fexinidazole and nifurtimox plus eflornithine in the treatment of African Trypanosomiasis: A systematic review.2021Cureus